Literature DB >> 28191509

Identifying the optimal blood pressure target for ideal health.

Xianglin Zhang1, Fangfang Fan2, Yong Huo2, Xiping Xu1.   

Abstract

Year:  2016        PMID： 28191509      PMCID： PMC5290906          DOI： 10.1515/jtim-2016-0001

Source DB:  PubMed          Journal:  J Transl Int Med        ISSN： 2224-4018


× No keyword cloud information.
  36 in total

1.  Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.

Authors:  Peter S Sever; Björn Dahlöf; Neil R Poulter; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal:  Lancet       Date:  2003-04-05       Impact factor: 79.321

2.  Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

3.  Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial.

Authors:  Yuquing Zhang; Xuezhong Zhang; Lisheng Liu; Alberto Zanchetti
Journal:  Eur Heart J       Date:  2011-02-22       Impact factor: 29.983

4.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

5.  The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients.

Authors:  Lisheng Liu; Yuqing Zhang; Guozhang Liu; Wei Li; Xuezhong Zhang; Alberto Zanchetti
Journal:  J Hypertens       Date:  2005-12       Impact factor: 4.844

6.  MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-13

7.  Treatment of mild hypertension: a five year controlled drug trial. The Oslo study.

Authors:  A Helgeland
Journal:  Am J Med       Date:  1980-11       Impact factor: 4.965

8.  2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension.

Authors: 
Journal:  J Hypertens       Date:  2013-10       Impact factor: 4.844

9.  Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial.

Authors:  Paolo Verdecchia; Jan A Staessen; Fabio Angeli; Giovanni de Simone; Augusto Achilli; Antonello Ganau; Gianfrancesco Mureddu; Sergio Pede; Aldo P Maggioni; Donata Lucci; Gianpaolo Reboldi
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321

10.  The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.

Authors:  S Klahr; A S Levey; G J Beck; A W Caggiula; L Hunsicker; J W Kusek; G Striker
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245
View more
  3 in total

1.  Role of combined propofol and sufentanil anesthesia in endoscopic injection sclerotherapy for esophageal varices.

Authors:  Yang Yu; Sheng-Lin Qi; Yong Zhang
Journal:  World J Gastroenterol       Date:  2017-11-28       Impact factor: 5.742

2.  Expression of miR-204 in pediatric retinoblastoma and its effects on proliferation and apoptosis of cancer cells.

Authors:  Jian Ding; Xiaoyun Lu
Journal:  Oncol Lett       Date:  2018-09-27       Impact factor: 2.967

3.  Effects of Different Treatment Methods on the Clinical and Urodynamic State of Perimenopausal Women with Stress Urinary Incontinence.

Authors:  Lifen Liu; Ying Zhang; Jingya Gong; Xin Chen; Hongmei Wu; Weipei Zhu
Journal:  Iran J Public Health       Date:  2018-08       Impact factor: 1.429
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.